Topical pain relief:

Indications for: LIDODERM

Postherpetic neuralgia (PHN).

Adult Dosage:

Apply to intact skin, covering most painful area. To adjust dose, cut patches before removing release liner. Remove if irritation or burning occurs; do not reapply until irritation subsides. May apply up to 3 patches at once for up to 12hrs of a 24-hour period. Hepatic impairment or debilitated: use smaller treatment areas.

Children Dosage:

Not established.

LIDODERM Warnings/Precautions:

Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants <6 months of age, concurrent exposure to oxidizing agents or metabolites); monitor. Accidental exposure to children and pets. Do not apply to broken or inflamed skin. Avoid eyes, mucous membranes, longer duration of application, and application of more than 3 patches. Avoid direct external heat sources (eg, heating pads, electric blankets). History of drug sensitivities. Hepatic disease. Small patients. Pregnancy (Cat.B). Labor & delivery. Nursing mothers.

LIDODERM Classification:

Topical anesthetic.

LIDODERM Interactions:

Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, others. Toxicity may be potentiated by Class I antiarrhythmics (eg, tocainide, mexiletine). Additive effects with other products containing local anesthetics.

Adverse Reactions:

Local effects (eg, erythema, edema), allergic reactions (eg, urticaria, angioedema, bronchospasm).

Generic Drug Availability:


How Supplied:

Patches (10cm x 14cm)—30